Evidence map›Paper›PMID 22645144›Full record

ArticleThe Journal of biological chemistry2012

Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic α2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation.

Jun Yang, Michael Dolinger, Gabrielle Ritaccio, Joseph Mazurkiewicz, David Conti, Xinjun Zhu, Yunfei Huang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Congenital Hyperinsulinism and Maple Syrup Urine Disease: A Challenging CombinationJournal of clinical research in pediatric endocrinology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Unveiling the Metabolic Effects of Glycomacropeptide.International journal of molecular sciences · 2021
    Article
  18. Review
  19. Article
  20. Amino Acids in Cell Signaling: Regulation and Function.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jun YangCenter for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA.
Michael Dolinger
Gabrielle Ritaccio
Joseph Mazurkiewicz
David Conti
Xinjun Zhu
Yunfei Huang
Albany Medical Center Hospital · US

Funding

The mTOR pathway in neuronal death and epileptogenesisR01NS062068 · NINDS · ALBANY MEDICAL COLLEGE · PI HUANG, YUNFEI · 2008 to 2011
$1.2M
NHE3 Polymorphisms and Chronic Diarrheal DiseasesK08DK088950 · NIDDK · ALBANY MEDICAL COLLEGE · PI ZHU, XINJUN · 2010 to 2014
$691k
NIDDK NIH HHS K08 DK088950NIDDK NIH HHS K08DK088950NINDS NIH HHS NS062068NINDS NIH HHS R01 NS062068
6 · The paper itself

Abstract

The amino acid leucine is a potent secretagogue, capable of inducing insulin secretion. It also plays an important role in the regulation of mTOR activity, therefore, providing impetus to investigate if a leucine-sensing mechanism in the mTOR pathway is involved in insulin secretion. We found that leucine-induced insulin secretion was inhibited by both the mTOR inhibitor rapamycin as well as the adrenergic α2 receptor agonist clonidine. We also demonstrated that leucine down-regulated the surface expression of adrenergic α2A receptor via activation of the mTOR pathway. The leucine stimulatory effect on insulin secretion was attenuated in diabetic Goto-Kakizaki rats that overexpress adrenergic α2A receptors, confirming the role of leucine in insulin secretion. Thus, our data demonstrate that leucine regulates insulin secretion by modulating adrenergic α2 receptors through the mTOR pathway. The role of the mTOR pathway in metabolic homeostasis led us to a second important finding in this study; retrospective analysis of clinical data showed that co-administration of rapamycin and clonidine was associated with an increased incidence of new-onset diabetes in renal transplantation patients over those receiving rapamycin alone. We believe that inhibition of mTOR by rapamycin along with activation of adrenergic α2 receptors by clonidine represents a double-hit to pancreatic islets that synergistically disturbs glucose homeostasis. This new insight may have important implications for the clinical management of renal transplant patients.

Indexed as

AnimalsBlood GlucoseBlotting, WesternCell LineDiabetes MellitusDown-RegulationHumansImmunoprecipitationInsulinInsulin SecretionKidney TransplantationLeucineMaleMicroscopy, ConfocalMicroscopy, FluorescenceRatsBlood GlucoseInsulinLeucinemTOR protein, ratTOR Serine-Threonine Kinases

Identifiers

PMID22645144
PMCPMC3397906
OpenAlexW2068054275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.